Amyris sells Squalane, Neossance, and CleanScreen to Givaudan

In California, synthetic biology firm Amyris has sold three ingredients to beauty and fragrance major Givaudan. The products sold include performant emollient Neossance® Squalane; plant-based silicone alternative Neossance® Hemisqualane; and sun protector CleanScreen.

Givaudan and Amyris also signed a long-term partnership agreement under which Amyris will continue to manufacture ingredients for Givaudan to use in cosmetics, as well as provide access to their innovation capabilities. Givaudan will become the commercialization partner for future sustainable beauty ingredients.

“Our technology and biomanufacturing capabilities deliver truly differentiated sustainable ingredients that are what consumers are demanding and enable our partners to lead in their markets,” John Melo, Amyris President and CEO, says in a press statement. “This transaction is a major step forward in funding our growth and enabling us to reach operating profitability.”

Further details have not been disclosed. The active cosmetic ingredients business would have represented approximately $30 million of incremental sales to Givaudan’s results in 2022 on a proforma basis.